Records containing: Overactive Bladder
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2020-03-02A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Oral Solabegron Modified Release Tablets in the Treatment of Overactive Bladder (OAB) in Adult Female Subjects
-
CLINICAL_TRIALS study record update · 2020-02-26Foot/Hand Neuromodulation for Overactive Bladder (OAB)
-
CLINICAL_TRIALS study record update · 2020-02-21'The Experience Sampling Method (ESM): a Real-time Patient-Reported Outcome Measure for Symptom Assessment in Patients With Overactive Bladder Syndrome.'
-
CLINICAL_TRIALS study record update · 2020-02-19A Double Blind, Randomized Four Way Cross Over Study to Compare the Effect of Fesoterodine 4mg and 8mg Once Daily and Oxybutynin 5mg Twice Daily After Steady State Dosing Versus Placebo on Cognitive Function in Subjects With Overactive Bladder, Over the Age of 75 Years With Mild Cognitive Impairment
-
CLINICAL_TRIALS study record update · 2020-02-07A Therapeutic Exploratory Clinical Study to Evaluate the Efficacy and Safety of DA-8010 in Patients With Overactive Bladder
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-01-03Posterior Tibial Nerve Stimulation's Effectiveness in UI Frequency in Overactive Patients in Home
-
CLINICAL_TRIALS study record update · 2019-12-11Prevention of Fall in Older Adults With Overactive Bladdar
-
CLINICAL_TRIALS study record update · 2019-12-05First in Human (FIH) Study for the Evaluation of the Safety and Early Performance of the Vibe Delivery System for the Delivery of Botox™ in Subjects With Idiopathic Overactive Bladder (OAB)
-
CLINICAL_TRIALS study record update · 2019-12-04Educating Patients on Management of Overactive Bladder: Written Versus Verbal Instructions
-
CLINICAL_TRIALS study record update · 2019-12-02Exploring Predictors of Symptoms Relapse After Discontinuation of Successful Treatment With a Tolterodine Prolonged Release Capsules (4 mg, Once Daily) in Overactive Bladder Patients: A Prospective Randomized Multicenter Trial
-
CLINICAL_TRIALS study record update · 2019-12-02Urinary NGF, PGE2 and ATP: Potential Biomarkers for Diagnosis and Prediction of Treatment Efficacy in Overactive Bladder Patients
-
CLINICAL_TRIALS study record update · 2019-12-02Comparison of the Efficacy and Safety of Combination Treatment With Doxazosin Plus TolterodineSR 2 mg vs Doxazosin Plus TolterodineSR 4 mg in Men With an OAB/BPO: Randomized Controlled Study"
-
CLINICAL_TRIALS study record update · 2019-11-22A Phase II, International, Multi-centre, Prospective, Randomised, Parallel-group, Double-blind, Dose-ranging, Placebo-controlled, 12-week, Princeps Study to Assess the Efficacy and Safety of a One Injection Cycle With Either Botulinum Toxin Type-A (Dysport® 125, 250 or 500 Units) or Placebo Followed by an Optional 6-month Extension Phase in the Symptomatic Treatment of Micturition Urgency and Frequency in Continent Female Subjects Suffering From Idiopathic Overactive Bladder.
-
CLINICAL_TRIALS study record update · 2019-11-14Effect of Potentially Irritating Beverages on Overactive Bladder Symptoms
-
CLINICAL_TRIALS study record update · 2019-10-23A Randomized Trial of Transcutaneous Nerve Stimulation for Overactive Bladder Patients
-
CLINICAL_TRIALS study record update · 2019-10-15Pelvic Floor Electromyography Monitoring as Tool to Improve Patient Selection and Outcome - Standardization of Lead Placement for Sacral Neuromodulation.
-
CLINICAL_TRIALS study record update · 2019-10-15Pelvic Floor EMG Monitoring as Tool to Improve Patient Selection and Outcome - Standardization of Lead Placement for Sacral Neuromodulation.
-
CLINICAL_TRIALS study record update · 2019-10-15Assessment of Predictive Role of Urodynamics in Sacral Neuromodulation Patients
-
CLINICAL_TRIALS study record update · 2019-10-02A Phase 4, Double-Blind, Randomized, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With Overactive Bladder (OAB) Symptoms While Taking the Alpha Blocker Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)
-
CLINICAL_TRIALS study record update · 2019-09-04Does Bladder Training (BT) Improve the Efficacy of Percutaneous Tibial Nerve Stimulation (PTNS) in Women With Refractory Overactive Bladder (OAB) - A Randomised Controlled Study
-
CLINICAL_TRIALS study record update · 2019-08-28The Effect of Information, Motivation, Behavioral Skills Model on Urinary Incontinence and Quality of Life in Men With Overactive Bladder: A Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2019-08-20The Effect of Low Intensity Extracorporeal Low Energy Shock Wave Therapy on Stress Urinary Incontinence and Overactivity Bladder
-
CLINICAL_TRIALS study record update · 2019-07-30Efficacy and Tolerability of Fesoterodine and Oxybutynin XL for Overactive Bladder Syndrome in Children: a Comparative Study.
-
CLINICAL_TRIALS study record update · 2019-07-30Efficacy and Tolerability of Fesoterodine for Overactive Bladder Syndrome in Children: an Extension Study.
-
CLINICAL_TRIALS study record update · 2019-07-19The Impact of Pre-procedure Periurethral Topical Lidocaine Application on Pain Scores After Complex Urodynamic Testing in Women